Form 4 for SER Serina Therapeutics, Inc.
Accepted 2026-07-09 12:05:12 ET · period of report 2026-07-07 · accession 0001777631-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-09 12:05 | 2026-07-07 | SER | Brannan Stephen K. | Dir | P - Purchase | $2.03 | +1,000 | 1,000 | New | +$2,030 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-07 | P | A | 1,000 | $2.03 | 1,000 | D | — | — |